Sequential Bispecific Antibodies and CAR-T Use Is a Safe and Effective Strategy in Relapsed Refractory Hematologic Malignancies
Fields of Study & Subjects
CAR-T cell therapy research
Protein Degradation and Inhibitors
Immunotherapy and Immune Responses
Publication details
- Journal / source
- Transplantation and Cellular Therapy
- Volume
- 32
- Issue
- 2
- Pages
- S203–S204
- Publication date
- 1 February 2026
- Language
- EN